All In Biotech

Free tool

FAERS Monitor: Sovaldi

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212480 or its brand name (Sovaldi, Sofosbuvir). Reports on generic versions are filed under their own applications.

Reports

19,622

Serious

14,219

72% of reports

Hospitalization

4,454

Death reported

1,800

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,317
  • drug ineffective1,931
  • hepatitis c1,736
  • headache1,646
  • nausea1,398
  • off label use1,389
  • anaemia1,190
  • insomnia1,065
  • hepatocellular carcinoma911
  • treatment failure837
  • dyspnoea789
  • asthenia781
  • diarrhoea746
  • dizziness716
  • pruritus712

Reports by year received

View as table
YearReports
20091
20111
20122
201339
20143,690
20155,519
20164,033
20172,503
20181,579
20191,127
2020353
2021198
2022195
2023141
2024139
202579
202623

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,034,537 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hepatitis cSignal1,736179.8171.2264,360
hepatocellular carcinomaSignal911145.7136.2115,192
treatment failureSignal83710.910.27,494
anaemiaSignal1,1906.76.45,809
insomniaSignal1,0654.34.12,717
fatigueSignal2,3173.23.13,619
headacheSignal1,6462.82.71,984
astheniaSignal7812.22.1536
pruritus7122.01.8354
nausea1,3981.91.8612
off label use1,3891.71.6418
drug ineffective1,9311.61.5427
dizziness7161.51.4138
dyspnoea7891.51.4132
diarrhoea7461.21.235

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.